About Bio Green Med Solution, Inc.
Bio Green Med Solution, Inc. is a publicly listed company based in Berkeley Heights (United States) founded in 1996. A diversified company in fire protection and biopharmaceuticals is operated. It operates on a Professional Services and Direct-to-Consumer (D2C) model. Bio Green Med Solution, Inc. has raised $47.34 million across 15 funding rounds from investors including Gov.uk, Credit Suisse and NIH. The company has 12 employees. Bio Green Med Solution, Inc. offers products and services including Fire Safety Equipment and Plogosertib. Its focus areas include Biotechnology, Cancer Therapeutics, Industrials and Safety Equipment. Its competitors include C4 Therapeutics, Erasca and MiRagen; 3 of its 3 listed competitors have raised funding.
Company details
Bio Green Med Solution, Inc. is engaged in both fire protection and biopharmaceutical sectors. Operations are conducted through its Fire Safety division, incorporating Fitters Sdn. Bhd., which specializes in supplying and trading fire safety equipment. In biopharmaceuticals, innovative cancer medicines are developed based on cell cycle, epigenetics, and mitosis biology. The company is headquartered in Kuala Lumpur, Malaysia, with a focus on creating sustainable value across these sectors. Long-term value creation for shareholders is prioritized while opportunities in both industries are advanced.
- Headquarters Berkeley Heights, United States
- Employees 12
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website cyclacel.com
- Social LinkedIn Facebook
- Legal Name Cyclacel Pharmaceuticals, Inc.
- Annual Revenue$747 K (USD)1637.21as on Dec 31, 2025
- Net Profit-$14.03 M (USD)-25.14as on Dec 31, 2025
- EBITDA-$8.42 M (USD)46.4as on Dec 31, 2025
- Total Equity Funding$47.34M (USD)
in 15 rounds
- Latest Funding Round$3M (USD), Post-IPO
Jun 2025
- InvestorsGov.uk
& 12 more
- Employee Count12
Products & Services of Bio Green Med Solution, Inc.
Bio Green Med Solution, Inc. offers a comprehensive portfolio of products and services, including Fire Safety Equipment and Plogosertib.
Various protective equipment for fire safety is provided.
Innovative cancer medicine based on cell cycle biology.
Funding Insights of Bio Green Med Solution, Inc.
Bio Green Med Solution, Inc. has successfully raised a total of $47.34M across 15 strategic funding rounds. The most recent funding activity was a Post-IPO round of $3 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $47.34M
- Total Rounds 15
- Last Round Post-IPO — $3M
- First Round $6.61M
(Aug 1999)
- Investors Count 13
Latest 10 of 15 funding rounds of Bio Green Med Solution, Inc. with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2025 | $3M | Post-IPO | – | – | – |
| Mar 2025 | $1M | Post-IPO | – | – | – |
| Nov 2024 | $2.06M | Post-IPO | – | – | – |
| May 2024 | $8M | Post-IPO | – | – | – |
| Dec 2023 | Post-IPO | – | – | – | |
| Jan 2021 | $7M | Post-IPO | – | – | – |
| Mar 2020 | Post-IPO | – | – | ||
| Nov 2012 | $1.9M | Grant | – | – | |
| Apr 2012 | $3.04M | Post-IPO | – | – | – |
| Oct 2010 | $15.2M | Post-IPO | – | – | – |
13 investors in total: 13 institutional.
Investors in Bio Green Med Solution, Inc.
Bio Green Med Solution, Inc. has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, Credit Suisse and NIH.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on healthcare companies | altapartners.com | Jackson, United States | ||
Venture capital firm focused on life science companies | 1986 | archventure.com | Chicago, United States | |
| vectorfund.com | ||||
Venture capital investments are offered by Fluke Venture Partners. | flukeventures.com | Kirkland, United States | ||
Mid-market investment bank | 1984 | roth.com | Newport Beach, United States | |
Online government services and information are provided to users. | 1707 | gov.uk | London, United Kingdom | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Invests in biotech firms developing life-saving drugs and technologies. | mpmcapital.com | |||
Wealth management, asset management, and investment banking services are offered. | 1856 | credit-suisse.com | Zurich, Switzerland |
Investor details for Bio Green Med Solution, Inc.
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
IPO & Listings of Bio Green Med Solution, Inc.
Bio Green Med Solution, Inc. is a publicly listed company on the NASDAQ with ticker symbol CYCC in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date31 Mar 2006
- Listed onNASDAQ: CYCC
- Listed entityCyclacel Pharmaceuticals, Inc.
- Exchange sectorHealth technology
- ISINUS23254L8761
- Share price$6.37 (-5.98% on the day) · 2025-09-12
- Market capitalisation$14.3M
- EPS (diluted, trailing year)$-301.80
- Volume (last session)220,471
- Analyst consensusNeutral
Financials of Bio Green Med Solution, Inc.
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $747,000 | -$14.0M | -$8.4M |
| 2024 | $43,000 | -$11.2M | -$15.7M |
| 2023 | $420,000 | -$22.6M | -$30.3M |
| 2022 | -$21.2M | -$30.9M | |
| 2021 | -$18.9M | -$22.9M |
Detailed financial statements for Bio Green Med Solution, Inc.
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Bio Green Med Solution, Inc.
4 dated milestones of Bio Green Med Solution, Inc. across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Bio Green Med Solution, Inc. is founded.
- Funding First funding round of $6.6M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $3.0M.
Competitors of Bio Green Med Solution, Inc.
Bio Green Med Solution, Inc. has 3 listed competitors in our database, 3 of them funded. They include C4 Therapeutics, Erasca and MiRagen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| c4therapeutics.com | 2016 | Cambridge, United States | $223M | 121 | Small-molecule drugs for cancer treatment are developed via Degronimid platform. | |
| erasca.com | 2018 | San Diego, United States | $300M | 120 | Small molecule therapeutics for cancer treatment are developed. | |
| miragen.com | 2007 | Boulder, United States | $111.29M | 92 | MicroRNA-based therapeutics are developed for treating multiple diseases. |
Detailed competitors of Bio Green Med Solution, Inc.
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bio Green Med Solution, Inc.
Websites that share an audience with Bio Green Med Solution, Inc. (cyclacel.com).
Websites whose visitors overlap most with Bio Green Med Solution, Inc.. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
kinexpharma.com | kinexpharma.com | 100% | – | ||
| immunicum.se | 98% | View details | |||
| inovio.com | 98% | 11.7K | #1,670,423 | View details | |
| angiodynamics.com | 66% | 18K | #1,595,457 | View details | |
| cancer.ca | 62% | #51,788 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Bio Green Med Solution, Inc.
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Oncology
3 companies that operate in the same segment as Bio Green Med Solution, Inc. (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bio Green Med Solution, Inc.
Complete news archive for Bio Green Med Solution, Inc.
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bio Green Med Solution, Inc.
Bio Green Med Solution, Inc. was founded in 1996 and raised its 1st funding round 3 years after it was founded.
Bio Green Med Solution, Inc. is headquartered in Berkeley Heights, United States. It is registered at Berkeley Heights, New Jersey, United States.
Bio Green Med Solution, Inc. is a funded company, having raised a total of $47.34M across 15 funding rounds to date. The company's 1st funding round was a Post-IPO of $15.2M, raised on Aug 1999.
Bio Green Med Solution, Inc. has 12 employees.
Annual revenue of Bio Green Med Solution, Inc. is $747K as on Dec 31, 2025.
Bio Green Med Solution, Inc. is engaged in both fire protection and biopharmaceutical sectors. Operations are conducted through its Fire Safety division, incorporating Fitters Sdn. Bhd., which specializes in supplying and trading fire safety equipment. In biopharmaceuticals, innovative cancer medicines are developed based on cell cycle, epigenetics, and mitosis biology. The company is headquartered in Kuala Lumpur, Malaysia, with a focus on creating sustainable value across these sectors. Long-term value creation for shareholders is prioritized while opportunities in both industries are advanced.
Bio Green Med Solution, Inc.'s top competitors include C4 Therapeutics, Erasca and MiRagen.
Bio Green Med Solution, Inc. offers Fire Safety Equipment and Plogosertib.
Yes, Bio Green Med Solution, Inc. is publicly traded on NASDAQ under the ticker symbol CYCC.
Bio Green Med Solution, Inc. has 13 investors. Key investors include Gov.uk, Credit Suisse, NIH, Arch Venture Partners, and Tredegar.
Bio Green Med Solution, Inc. operates through Bio Green Med Solution, Inc..